GLP-1s fail to match trial hype in real life
By Megan Brodie 1 year ago | In Products, Regulatory, Reputation- 1 year ago
20 June 2025 Blockbuster GLP-1 RAs WEGOVY (semaglutide) and MOUNJARO (tirzepatide) have been found to…
This is subscriber-only content. Please login to continue reading.